Alkermes' (ALKS) Q4 Earnings & Revenues Surpass Estimates

Published on 15 Feb 2024 on Zacks via Yahoo Finance

Alkermes' (ALKS) Q4 Earnings & Revenues Surpass Estimates

Alkermes plc ALKS reported fourth-quarter 2023 adjusted earnings of 48 cents per share, which beat the Zacks Consensus Estimate of 46 cents. The company had reported adjusted earnings of 40 cents per share in the year-ago quarter.

ALKS’ revenues of $377.5 million surged almost 24% from the year-ago quarter’s level owing to strong performance of its proprietary products portfolio. The top line also beat the Zacks Consensus Estimate of $361.2 million.

Quarter in Detail

Read the rest of the article

NASDAQ.ALKS price evolution

NASDAQ.PBYI price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise

Shares of Viatris, Inc. VTRS lost 4.8% in the last three trading sessions after the company repor...

Zacks via Yahoo Finance 5 Mar 2024

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript February 29, 2024 Puma Bi...

Insider Monkey via Yahoo Finance 2 Mar 2024

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimate

Key Insights Puma Biotechnology's estimated fair value is US$11.07 based on 2 Stage Free Cash Flo...

Simply Wall St. via Yahoo Finance 2 Mar 2024

Why Puma Biotech (PBYI) is a Top Value Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidenc...

Zacks via Yahoo Finance 1 Mar 2024

Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023

Net Income: PBYI reported a net income of $12.3 million in Q4 2023, a significant improvement fro...

GuruFocus.com via Yahoo Finance 1 Mar 2024

Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates

Puma Biotechnology, Inc. PBYI reported fourth-quarter 2023 adjusted earnings of 31 cents per shar...

Zacks via Yahoo Finance 1 Mar 2024

Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks

Novavax, Inc. NVAX reported a fourth-quarter 2023 loss of $1.44 cents per share, much wider than ...

Zacks via Yahoo Finance 29 Feb 2024

Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates

Theravance Biopharma, Inc. TBPH reported fourth-quarter 2023 adjusted net income of 3 cents per s...

Zacks via Yahoo Finance 27 Feb 2024

Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?

We expect investors to focus on Puma Biotechnology, Inc.’s PBYI progress with its sole marketed d...

Zacks via Yahoo Finance 27 Feb 2024

Fate Therapeutics (FATE) Q4 Earnings Beat, Revenues Fall Y/Y

Fate Therapeutics FATE reported fourth-quarter 2023 loss of 45 cents per share, narrower than the...

Zacks via Yahoo Finance 27 Feb 2024

News

Alkermes' (ALKS) Q4 Earnings & Revenues Surpass Estimates

NASDAQ.ALKS price evolution

NASDAQ.PBYI price evolution

Want to become a better investor?